Robert Finke, Pharm D.

Analyst

Dr. Finke joined Great Point Partners in 2024. 

Prior to this, he worked in biotechnology research at Guggenheim Securities.

He received his Pharm.D. magna cum laude from the University of Rhode Island and his M.B.A. from Indiana University.